Table 2.
Clinical and histopathological characteristics of cervical cancer patients in TASH cancer center (n = 634)
| Variables | Code | Baseline anemia | Total N (%) | |
|---|---|---|---|---|
| Yes N (%) | No N (%) | |||
| Stage | Stage I | 26(41.26) | 37(58.73) | 63(9.93) |
| Stage II | 70(44.31) | 88(55.69) | 158(24.92) | |
| Stage III | 118(46.27) | 137(53.72) | 255(40.22) | |
| Stage IV | 109(68.99) | 49(31.01) | 158(24.92) | |
| Histopathology | Squamous cell | 299(52.09) | 275(47.91) | 574(90.54) |
| Adenocarcinoma | 24(40.00) | 36(60.00) | 60(9.46) | |
| Comorbidity | Yes | 152(71.70) | 60(28.30) | 212(33.44) |
| No | 171(40.52) | 251(59.48) | 422(66.56) | |
| Types of comorbidity (n = 212) | HIV | 90(76.27) | 28(23.73) | 118(55.66) |
| Hypertension | 31(63.27) | 18(36.73) | 49(23.11) | |
| Others | 21(44.68) | 16(34.04) | 47(22.17) | |